Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis.
暂无分享,去创建一个
D. Cook | A. Rudnicka | C. Owen | A. Fletcher | R. Wormald | V. Kapetanakis | Andrea K Wathern | ALICJA R. RUDNICKA | VENEDIKTOS V. KAPETANAKIS | ZAKARIYA JARRAR | ANDREA K. WATHERN | RICHARD WORMALD | ASTRID E. FLETCHER | DEREK G. COOK | CHRISTOPHER G. OWEN | Zakariya A. Jarrar | Andrea K. Wathern
[1] R. Klein,et al. Prevalence of age-related macular degeneration in the US population. , 2011, Archives of ophthalmology.
[2] P T de Jong,et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .
[3] T. Peto,et al. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. , 2003, Ophthalmology.
[4] C. Delcourt,et al. The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study. , 2005, American journal of ophthalmology.
[5] Paul Mitchell,et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.
[6] Liang Xu,et al. Mortality and ocular diseases: the Beijing Eye Study. , 2009, Ophthalmology.
[7] G. Jensen,et al. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. , 2005, Ophthalmology.
[8] P. Mitchell,et al. Smoking and age-related macular degeneration: a review of association , 2005, Eye.
[9] A. Hofman,et al. REVIEW: Epidemiology of age-related maculopathy: a review , 2003, European Journal of Epidemiology.
[10] James Waterman Glover. United States Life Tables , 2013 .
[11] Ronald Klein,et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2007, Ophthalmology.
[12] S. Cummings,et al. The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the Study of Osteoporotic Fractures. , 2010, American journal of ophthalmology.
[13] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[14] E. Arias,et al. United States life tables, 2006. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[15] A. Hofman,et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. , 2003, Archives of ophthalmology.
[16] Frank Eperjesi,et al. Risk Factors for Age-related Macular Degeneration , 2011 .
[17] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.
[18] D. Moore,et al. Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. , 2003, Health technology assessment.
[19] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[20] P. Mitchell,et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis , 2010, BMC ophthalmology.
[21] D. Cook,et al. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. , 2006, Investigative ophthalmology & visual science.
[22] Paul Mitchell,et al. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. , 2007, Ophthalmology.
[23] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[24] B. Munoz,et al. Racial differences and other risk factors for incidence and progression of age-related macular degeneration: Salisbury Eye Evaluation (SEE) Project. , 2008, Investigative ophthalmology & visual science.
[25] J M Gibson,et al. Seven year follow-up of age-related maculopathy in an elderly British population , 1997, Eye.
[26] A Hofman,et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. , 2001, Investigative ophthalmology & visual science.
[27] A E Fletcher,et al. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? , 2003, The British journal of ophthalmology.
[28] T. Wong,et al. Age-related macular degeneration: why should stroke physicians care? , 2010, Stroke.
[29] Richard Wormald,et al. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. , 2012, Ophthalmology.
[30] Albert Hofman,et al. Epidemiology of age-related maculopathy: a review. , 2003, European journal of epidemiology.
[31] M G Maguire,et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. , 1995, Archives of ophthalmology.
[32] M. C. Leske,et al. Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy. , 1983, American journal of epidemiology.
[33] R. Bronow. Physicians who care. , 1987, Journal of the American Academy of Dermatology.
[34] B. Stegmayr,et al. Sex Differences in Stroke Epidemiology: A Systematic Review , 2009, Stroke.
[35] H. Taylor,et al. Five-year incidence of age-related maculopathy: the Visual Impairment Project. , 2004, Ophthalmology.
[36] L. Smeeth,et al. Cause-specific visual impairment and mortality: results from a population-based study of older people in the United Kingdom. , 2005, Archives of ophthalmology.
[37] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[38] Paul Mitchell,et al. Clinical update: new treatments for age-related macular degeneration , 2007, The Lancet.
[39] Paul Mitchell,et al. Visual impairment, age-related macular degeneration, cataract, and long-term mortality: the Blue Mountains Eye Study. , 2007, Archives of ophthalmology.
[40] P. Mitchell,et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. , 2010, Ophthalmology.